Over the past 12 months, 5 insiders at Krystal Biotech, Inc. filed 82 open-market SEC Form 4 transactions on KRYS: 0 purchases worth $0 and 82 sales worth $62.8M. Insiders have been net sellers over this period. The most recent filing was on Mar 4, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 26 | Krish S KrishnanPresident and CEO | SELL | 8.8K | $266.56 | $2.3M |
| Mar 4, 26 | Suma KrishnanPresident, R&D | SELL | 6.0K | $266.42 | $1.6M |
| Mar 2, 26 | Kathryn RomanoChief Accounting Officer | SELL | 750 | $267.60 | $201K |
| Feb 27, 26 | Daniel JanneyDirector | SELL | 9.4K | $276.17 | $2.6M |
| Feb 26, 26 | Daniel JanneyDirector | SELL | 5.1K | $276.32 | $1.4M |
| Feb 25, 26 | Daniel JanneyDirector | SELL | 700 | $275.00 | $193K |
| Feb 24, 26 | Daniel JanneyDirector | SELL | 11.7K | $274.90 | $3.1M |
| Feb 19, 26 | Dino A RossiDirector | SELL | 10.8K | $262.10 | $2.8M |
| Feb 9, 26 | Kathryn RomanoChief Accounting Officer | SELL | 5.7K | $277.88 | $1.5M |
| Dec 4, 25 | Krish S KrishnanPresident and CEO | SELL | 10.5K | $222.38 | $2.3M |
| Dec 4, 25 | Suma KrishnanPresident, R&D | SELL | 10.5K | $222.38 | $2.3M |
| Jul 16, 25 | Krish S KrishnanPresident and CEO | SELL | 1.5K | $150.00 | $229K |
| Jul 16, 25 | Suma KrishnanPresident, R&D | SELL | 1.5K | $150.00 | $229K |
| Jul 15, 25 | Krish S KrishnanPresident and CEO | SELL | 2.2K | $151.79 | $337K |
| Jul 15, 25 | Suma KrishnanPresident, R&D | SELL | 2.2K | $151.79 | $337K |
| Jul 14, 25 | Krish S KrishnanPresident and CEO | SELL | 13.4K | $151.00 | $2.0M |
| Jul 14, 25 | Suma KrishnanPresident, R&D | SELL | 13.4K | $151.00 | $2.0M |
| Jul 10, 25 | Krish S KrishnanPresident and CEO | SELL | 6.6K | $151.39 | $996K |
| Jul 10, 25 | Suma KrishnanPresident, R&D | SELL | 6.6K | $151.39 | $996K |
| Jul 9, 25 | Krish S KrishnanPresident and CEO | SELL | 200 | $150.14 | $30K |
| Jul 9, 25 | Suma KrishnanPresident, R&D | SELL | 200 | $150.07 | $30K |
| Mar 13, 25 | Krish S KrishnanPresident and CEO | SELL | 10.9K | $179.57 | $1.9M |
| Mar 13, 25 | Suma KrishnanPresident, R&D | SELL | 10.9K | $179.57 | $1.9M |
| Feb 27, 25 | Kathryn RomanoChief Accounting Officer | SELL | 750 | $175.22 | $131K |
| Dec 13, 24 | Krish S KrishnanPresident and CEO | SELL | 8.9K | $171.63 | $1.5M |
| Dec 13, 24 | Suma KrishnanPresident, R&D | SELL | 8.9K | $171.63 | $1.5M |
| Sep 12, 24 | Krish S KrishnanPresident and CEO | SELL | 8.5K | $201.81 | $1.7M |
| Sep 12, 24 | Suma KrishnanPresident, R&D | SELL | 8.5K | $201.81 | $1.7M |
| Jun 11, 24 | Krish S KrishnanPresident and CEO | SELL | 6.4K | $178.36 | $1.1M |
| Jun 11, 24 | Suma KrishnanPresident, R&D | SELL | 6.4K | $178.36 | $1.1M |
| May 20, 24 | Julian S GangolliDirector | SELL | 10.9K | $165.76 | $1.8M |
| Mar 11, 24 | Krish S KrishnanPresident and CEO | SELL | 8.0K | $174.13 | $1.4M |
| Mar 11, 24 | Suma KrishnanPresident, R&D | SELL | 8.0K | $174.13 | $1.4M |
| Feb 28, 24 | Kathryn RomanoChief Accounting Officer | SELL | 1.6K | $172.23 | $264K |
| Feb 26, 24 | Kathryn RomanoChief Accounting Officer | SELL | 5.0K | $140.00 | $675K |
| Jan 22, 24 | Kathryn RomanoChief Accounting Officer | SELL | 2.5K | $130.00 | $325K |
| Dec 11, 23 | Krish S KrishnanPresident and CEO | SELL | 17.5K | $107.66 | $1.9M |
| Dec 11, 23 | Suma KrishnanPresident, R&D | SELL | 17.5K | $107.66 | $1.9M |
| Sep 11, 23 | Krish S KrishnanPresident and CEO | SELL | 10.6K | $129.10 | $1.4M |
| Sep 11, 23 | Suma KrishnanPresident, R&D | SELL | 10.6K | $129.10 | $1.4M |
| Jun 9, 23 | Andrew C. OrthChief Commercial Officer | SELL | 6.9K | $129.70 | $890K |
| Jun 9, 23 | Daniel JanneyDirector | SELL | 10.0K | $129.29 | $1.3M |
| Jun 8, 23 | Daniel JanneyDirector | SELL | 10.0K | $129.02 | $1.3M |
| May 31, 23 | Krish S KrishnanPresident and CEO | SELL | 20.1K | $117.61 | $2.3M |
| May 31, 23 | Suma KrishnanPresident, R&D | SELL | 20.1K | $117.61 | $2.3M |
| May 22, 23 | Kathryn RomanoChief Accounting Officer | SELL | 12.5K | $110.00 | $1.4M |
| May 19, 23 | Daniel JanneyDirector | SELL | 50.0K | $95.02 | $4.8M |
| May 19, 23 | Kathryn RomanoChief Accounting Officer | SELL | 12.5K | $95.08 | $1.2M |
| May 9, 23 | Daniel JanneyDirector | SELL | 17.1K | $90.74 | $1.6M |
| Apr 19, 23 | Daniel JanneyDirector | SELL | 7.9K | $90.32 | $714K |
Over the past 12 months, insiders at Krystal Biotech, Inc. filed 0 open-market purchases worth $0 and 82 sales worth $62.8M on KRYS, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 4, 26.
5 different insiders at Krystal Biotech, Inc. filed open-market SEC Form 4 transactions on KRYS over the last 12 months.
InsiderTape plots every KRYS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Krystal Biotech, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →